159 results on '"Köhl, U."'
Search Results
2. Development of adaptive immune effector therapies in solid tumors
3. Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey
4. Molekulare und zellbasierte Krebstherapie – Quo vadis?
5. Was ist gesichert bei den Zelltherapien?: Möglichkeiten und Grenzen in der Immunonkologie
6. WHAT COULD BE THE FUTURE OF GENETICALLY MODIFIED LYMPHOCYTES IN MDS?
7. Immunotherapy: IN-DEPTH CHARACTERIZATION OF THE IMMUNE MICROENVIRONMENT OF PATIENTS UNDERGOING CAR T CELL THERAPY
8. Selection and validation of siRNAs preventing uptake and replication of SARS-CoV-2
9. IS34 - WHAT COULD BE THE FUTURE OF GENETICALLY MODIFIED LYMPHOCYTES IN MDS?
10. Immunotherapy: NOVEL STRATEGIES TO ENHANCE THE SAFETY OF CAR T CELL IMMUNOTHERAPY: THE IMSAVAR PROJECT
11. Urologie
12. Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
13. Positive Selection of Hematopoietic Progenitor Cells for Autologous and Allogeneic Transplantation in Pediatric Patients with Solid Tumors and Leukemia
14. Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation
15. Cytotoxic Activity and Pharmacology of an Ara-CMP Prodrug in T-leukemic Sublines Resistant to Ara-C
16. Effect of Combined Treatment with 4-Hydroperoxycyclophosphamide and Fludarabine on Cytotoxicity and Repair of Damaged DNA
17. Kontinentes Appendixstoma — Modifikation der Mainz-Pouch Technik
18. Kontinente Harnableitung versus Neoblase — Differentialindikation
19. Extracellular Vesicles of Mesenchymal Stromal Cells Can be Taken up by Microglial Cells and Partially Prevent The Stimulation Induced by β-Amyloid
20. First-in-human intracochlear application of human stromal cell-derived extracellular vesicles
21. GENERATION OF CLINICAL-GRADE CMV-SPECIFIC T-CELLS: T-CELL DONOR SELECTION AND MANUFACTURING OF T CELLS: PH-P484
22. PHENOTYPING AND FUNCTIONAL COMPARISON OF CMV-CTLS IN-VITRO EXPANDED WITH CONVENTIONAL AND SMART DENDRITIC CELLS: PH-P072
23. Extrazelluläre Vesikel als neues Therapeutikum in der Otologie
24. P09.08 Clinical-grade manufacturing of ROR1 CAR T cells using a novel virus-free protocol
25. G-CSF impairs the antiviral immune response of T-cells in stem cell donors: implications for the selection of CTL donors: O179
26. Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children
27. Adrenalektomie im Rahmen der Tumornephrektomie – ein Overtreatment?
28. CD34+-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation
29. Monitoring with tetramers enables detection of persistent recipient-derived CMV-specific T-cells: O196
30. Multiple (Five) synchronous primary malignant neoplasmas of dissimilar histogenesis including a malignant fibrous histiocytoma of the bladder
31. Urologie
32. Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance
33. Radical cystoprostatectomy combined with Mainz pouch bladder substitution to the urethra: long-term results
34. A simple device in the prevention of recurrent appendico-umbilical stenosis
35. 1009P Current strategies of cell and gene therapy for solid tumors: Preliminary results of the joint international ESMO and EBMT Cell Therapy and Immunobiology Working Party questionnaire-based survey
36. Virus-specific T cells from stem cell, family and third party T cell donors: Patient monitoring, donor selection and GMP-compliant manufacturing
37. Mainz-Pouch — Erfahrungen über 4 Jahre
38. Therapiekonzept beim Sinus urogenitalis
39. Indikation zur Zystektomie beim T1 G3-Blasenkarzinom
40. Tumors of the brachial plexus
41. Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation
42. 65 - Virus-specific T cells from stem cell, family and third party T cell donors: Patient monitoring, donor selection and GMP-compliant manufacturing
43. Mainz-Pouch — Erfahrungen über 4 Jahre
44. Therapiekonzept beim Sinus urogenitalis
45. T-helper lymphocyte subpopulations in type 1 diabetes: influence of the vitamin D status and CYP24A1 single nucleotide polymorphism
46. Multicolour flow cytometry quantification of immunoafinity selected CMV antigen specific T-cell in clinical scale preparations with two different devices
47. The regulation of advanced therapy medicinal products in europe and the role of academia
48. Experience with the Mainz modification of ureterosigmoidostomy
49. T1-Blasenkarzinom: Indikation zur transurethralen Elektroresektion oder zur primären radikalen Zystektomie?
50. Formation of cytosine arabinoside-5′-triphosphate in different cultured lymphoblastic leukaemic cells with reference to their drug sensitivity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.